The Israel Insider : Dec 29, 2020 GODTV.com
“Even as we see the introduction of numerous vaccines intended to reduce the transmission of the disease and protect vulnerable populations, this drug can help the direct treatment of the virus and reduce its severity and mortality. We hope to see the first results of the clinical phase of this study in the coming months.” -Professor Shlomo Maayan, Director of the Department of Infectious Diseases
[GODTV.com] Initial clinical data from the Hebrew University in Jerusalem shows the Fenofibrate has the ability to prevent lung damage in Coronavirus (COVID-19) patients, turning its effects into little more than the common cold. (Image: Unsplash-Lucas Vasques)
Fenofibrate, a medication of the fibrate class used to treat abnormal blood lipid levels, was found to reduce COVID-19 severity and mortality.
This finding has the potential to significantly change how Corona patients are being treated and the…
View original post 510 more words